# EDGAR Filing Document

**Accession Number:** 0001540013
**File Stem:** 0001104659-23-011761
**Filing Date:** 2023-2
**Character Count:** 4819
**Document Hash:** 8ce9a50a680c65125959dc68047f00e5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-011761.hdr.sgml**: 20230207

**ACCESSION NUMBER**: 0001104659-23-011761

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230207

**FILED AS OF DATE**: 20230207

**DATE AS OF CHANGE**: 20230207

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Quipt Home Medical Corp.
- **CENTRAL INDEX KEY:** 0001540013
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40413
- **FILM NUMBER:** 23595377

**BUSINESS ADDRESS:**
- **STREET 1:** 1019 TOWN DRIVE
- **CITY:** WILDER
- **STATE:** KY
- **ZIP:** 41076
- **BUSINESS PHONE:** 859-878-2220

**MAIL ADDRESS:**
- **STREET 1:** 1019 TOWN DRIVE
- **CITY:** WILDER
- **STATE:** KY
- **ZIP:** 41076

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Protech Home Medical Corp.
- **DATE OF NAME CHANGE:** 20200714

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Patient Home Monitoring Corp.
- **DATE OF NAME CHANGE:** 20120119

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

------

**FORM 6-K** 

**REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE** 

**SECURITIES EXCHANGE ACT OF 1934**

**For the month of February 2023**

**Commission File Number: 001-40413**

**Quipt Home Medical Corp.** 

**(Translation of registrant's name into English)** 

**1019 Town Drive**

**Wilder, Kentucky 41076**

**(Address of principal executive office)** 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ◻ Form 40-F ⌧

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ◻

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| **Exhibit** | **Description** |
| [99.1](tm235818d1_ex99-1.htm) | [News Release dated February 7, 2023](tm235818d1_ex99-1.htm) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
|  | **Quipt Home Medical Corp.** |
| Date: February 7, 2023 | /s/ *Gregory Crawford* |
|  | Chief Executive Officer |

---

## Exhibit 99.1

**Exhibit 99.1**

**Quipt Home Medical Announces DATE AND TIME**

**FOR FISCAL Q1 2023 CONFERENCE CALL AND AUDIO WEBCAST**

Cincinnati, Ohio – February 7, 2023 – Quipt Home Medical Corp. (the "**Company**") (NASDAQ: QIPT) (TSXV: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced that it will host its Fiscal Q1 2023 earnings conference call and audio webcast on Tuesday, February 14, 2023 at 10:00 a.m. (EST).

**<u>Conference Call Details:</u>**

Tuesday, February 14, 2023 at 10:00 a.m. (EST).

Canada/US Toll Free: 1 (800) 319 4610 <br> International: 1 (604) 638 5340

**<u>Audio Webcast Details:</u>**

The live audio webcast can be found on the investor section of the Company's website through the following link: <u>www.quipthomemedical.com</u>

**ABOUT QUIPT HOME MEDICAL CORP.**

The Company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. The primary business objective of the Company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The Company's organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient's services, and making life easier for the patient.

*Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.*

For further information please visit our website at <u>www.quipthomemedical.com</u>, or contact:

Cole Stevens

VP of Corporate Development

Quipt Home Medical Corp.

859-300-6455

<u>cole.stevens@myquipt.com</u>

Gregory Crawford

Chief Executive Officer

Quipt Home Medical Corp.

859-300-6455

<u>investorinfo@myquipt.com</u>